STOCK TITAN

[8-K] Viatris Inc Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Viatris Inc. amended and restated its bylaws effective October 24, 2025, updating proxy access timing rules when the annual meeting date shifts. The company set its 2026 annual meeting for May 15, 2026.

Shareholder deadlines: Rule 14a-8 proposals are due by November 24, 2025. Proxy access nominations (up to the greater of two nominees or 20% of the Board) must be received between December 16, 2025 and January 15, 2026. Advance notice for other director nominations or business must be delivered between January 15, 2026 and February 14, 2026. Universal proxy notices under Rule 14a-19 are due by March 16, 2026.

Viatris Inc. ha emendato e riformulato i propri statuti, con effetto dal 24 ottobre 2025, aggiornando le norme sui tempi di accesso al proxy quando la data dell'assemblea annuale cambia. L'azienda ha fissato l'assemblea annuale 2026 al 15 maggio 2026.

Scadenze per gli azionisti: le proposte ai sensi della Regola 14a-8 devono essere presentate entro il 24 novembre 2025. Le nomination per l'accesso al proxy (la quantità massima pari al minimo tra due nomination o il 20% del Consiglio) devono essere ricevute tra il 16 dicembre 2025 e il 15 gennaio 2026. L'avviso anticipato per altre nomination di direttori o questioni aziendali deve essere presentato tra il 15 gennaio 2026 e il 14 febbraio 2026. Le notifiche universali di proxy ai sensi della Regola 14a-19 devono essere inviate entro il 16 marzo 2026.

Viatris Inc. enmendó y reformuló sus estatutos vigentes a partir del 24 de octubre de 2025, actualizando las reglas de acceso a los representantes cuando la fecha de la asamblea anual cambia. La empresa fijó la asamblea anual de 2026 para el 15 de mayo de 2026.

Fechas límite para accionistas: las propuestas de la Norma 14a-8 deben presentarse antes del 24 de noviembre de 2025. Las nominaciones para acceso al proxy (hasta el mayor de dos nominados o el 20% de la Junta) deben recibirse entre el 16 de diciembre de 2025 y el 15 de enero de 2026. El aviso previo para otras nominaciones de directores o asuntos de negocios debe entregarse entre el 15 de enero de 2026 y el 14 de febrero de 2026. Los avisos de proxy universal conforme a la Regla 14a-19 deben presentarse antes del 16 de marzo de 2026.

바이아트리스 주식회사는 2025년 10월 24일부로 정관을 개정 및 재정비했으며, 연례 주주총회 일정이 변경될 때 대리인 접근 규정을 업데이트했습니다. 회사는 2026년 연례 주주총회를 2026년 5월 15일로 정했습니다.

주주 마감일: 규칙 14a-8에 따르면 제안서는 2025년 11월 24일까지 제출해야 합니다. 대리인 접근을 위한 지명(최대 두 명 또는 이사회 총수의 20% 중 큰 수)을 2025년 12월 16일부터 2026년 1월 15일 사이에 접수해야 합니다. 다른 이사 지명이나 사업을 위한 사전 통지는 2026년 1월 15일부터 2026년 2월 14일 사이에 전달되어야 합니다. 규칙 14a-19에 따른 보편적 프록시 통지는 2026년 3월 16일까지 제출되어야 합니다.

Viatris Inc. a amendé et révisé ses statuts avec effet au 24 octobre 2025, mettant à jour les règles d'accès au mandat lorsque la date de l'assemblée annuelle change. L'entreprise a fixé son assemblée annuelle 2026 au 15 mai 2026.

Dates limites pour les actionnaires : les propositions en vertu de la Règle 14a-8 doivent être déposées d'ici le 24 novembre 2025. Les nominations pour l'accès au proxy (jusqu'au plus élevé entre deux nominations ou 20 % du Conseil) doivent être reçues entre le 16 décembre 2025 et le 15 janvier 2026. L'avis préalable pour d'autres nominations de administrateurs ou des affaires doit être délivré entre le 15 janvier 2026 et le 14 février 2026. Les avis de proxy universels en vertu de la Règle 14a-19 doivent être déposés d'ici le 16 mars 2026.

Viatris Inc. hat seine Satzung mit Wirkung vom 24. Oktober 2025 geändert und neu gefasst und die Regeln zum Proxy-Zugriff angepasst, wenn sich das Datum der Hauptversammlung verschiebt. Das Unternehmen hat die Hauptversammlung 2026 auf den 15. Mai 2026 festgelegt.

Fristen für Aktionäre: Vorschläge gemäß Regel 14a-8 müssen bis zum 24. November 2025 eingereicht werden. Proxy-Zugriffs-Nominierungen (bis zur größeren Zahl von zwei Nominierungen oder 20% des Vorstands) müssen zwischen dem 16. Dezember 2025 und dem 15. Januar 2026 eingehen. Frühzeitige Hinweise für andere Direktoren-Nominierungen oder Geschäfte müssen zwischen dem 15. Januar 2026 und dem 14. Februar 2026 vorgelegt werden. Universelle Proxy-Benachrichtigungen gemäß Regel 14a-19 müssen bis zum 16. März 2026 erfolgen.

فيايتريس إنك عدّلت وصاغت من جديد نظامها bylaws اعتباراً من 24 أكتوبر 2025، محدثة قواعد الوصول إلى التوكيل عند تغير تاريخ الاجتماع السنوي. حدّدت الشركة اجتماعها السنوي 2026 في 15 مايو 2026.

المواعيد النهائية للمساهمين: يجب تقديم مقترحات القاعدة 14a-8 قبل 24 نوفمبر 2025. يجب استلام الترشيحات للوصول إلى التوكيل (حتى الأكبر من مرشّحين اثنين أو 20% من مجلس الإدارة) بين 16 ديسمبر 2025 و15 يناير 2026. يجب تقديم إشعار مسبَق لغيرها من ترشيحات الأعضاء أو الأعمال بين 15 يناير 2026 و14 فبراير 2026. يجب تقديم إشعارات التوكيل الشامل وفق القاعدة 14a-19 قبل 16 مارس 2026.

Positive
  • None.
Negative
  • None.

Viatris Inc. ha emendato e riformulato i propri statuti, con effetto dal 24 ottobre 2025, aggiornando le norme sui tempi di accesso al proxy quando la data dell'assemblea annuale cambia. L'azienda ha fissato l'assemblea annuale 2026 al 15 maggio 2026.

Scadenze per gli azionisti: le proposte ai sensi della Regola 14a-8 devono essere presentate entro il 24 novembre 2025. Le nomination per l'accesso al proxy (la quantità massima pari al minimo tra due nomination o il 20% del Consiglio) devono essere ricevute tra il 16 dicembre 2025 e il 15 gennaio 2026. L'avviso anticipato per altre nomination di direttori o questioni aziendali deve essere presentato tra il 15 gennaio 2026 e il 14 febbraio 2026. Le notifiche universali di proxy ai sensi della Regola 14a-19 devono essere inviate entro il 16 marzo 2026.

Viatris Inc. enmendó y reformuló sus estatutos vigentes a partir del 24 de octubre de 2025, actualizando las reglas de acceso a los representantes cuando la fecha de la asamblea anual cambia. La empresa fijó la asamblea anual de 2026 para el 15 de mayo de 2026.

Fechas límite para accionistas: las propuestas de la Norma 14a-8 deben presentarse antes del 24 de noviembre de 2025. Las nominaciones para acceso al proxy (hasta el mayor de dos nominados o el 20% de la Junta) deben recibirse entre el 16 de diciembre de 2025 y el 15 de enero de 2026. El aviso previo para otras nominaciones de directores o asuntos de negocios debe entregarse entre el 15 de enero de 2026 y el 14 de febrero de 2026. Los avisos de proxy universal conforme a la Regla 14a-19 deben presentarse antes del 16 de marzo de 2026.

바이아트리스 주식회사는 2025년 10월 24일부로 정관을 개정 및 재정비했으며, 연례 주주총회 일정이 변경될 때 대리인 접근 규정을 업데이트했습니다. 회사는 2026년 연례 주주총회를 2026년 5월 15일로 정했습니다.

주주 마감일: 규칙 14a-8에 따르면 제안서는 2025년 11월 24일까지 제출해야 합니다. 대리인 접근을 위한 지명(최대 두 명 또는 이사회 총수의 20% 중 큰 수)을 2025년 12월 16일부터 2026년 1월 15일 사이에 접수해야 합니다. 다른 이사 지명이나 사업을 위한 사전 통지는 2026년 1월 15일부터 2026년 2월 14일 사이에 전달되어야 합니다. 규칙 14a-19에 따른 보편적 프록시 통지는 2026년 3월 16일까지 제출되어야 합니다.

Viatris Inc. a amendé et révisé ses statuts avec effet au 24 octobre 2025, mettant à jour les règles d'accès au mandat lorsque la date de l'assemblée annuelle change. L'entreprise a fixé son assemblée annuelle 2026 au 15 mai 2026.

Dates limites pour les actionnaires : les propositions en vertu de la Règle 14a-8 doivent être déposées d'ici le 24 novembre 2025. Les nominations pour l'accès au proxy (jusqu'au plus élevé entre deux nominations ou 20 % du Conseil) doivent être reçues entre le 16 décembre 2025 et le 15 janvier 2026. L'avis préalable pour d'autres nominations de administrateurs ou des affaires doit être délivré entre le 15 janvier 2026 et le 14 février 2026. Les avis de proxy universels en vertu de la Règle 14a-19 doivent être déposés d'ici le 16 mars 2026.

Viatris Inc. hat seine Satzung mit Wirkung vom 24. Oktober 2025 geändert und neu gefasst und die Regeln zum Proxy-Zugriff angepasst, wenn sich das Datum der Hauptversammlung verschiebt. Das Unternehmen hat die Hauptversammlung 2026 auf den 15. Mai 2026 festgelegt.

Fristen für Aktionäre: Vorschläge gemäß Regel 14a-8 müssen bis zum 24. November 2025 eingereicht werden. Proxy-Zugriffs-Nominierungen (bis zur größeren Zahl von zwei Nominierungen oder 20% des Vorstands) müssen zwischen dem 16. Dezember 2025 und dem 15. Januar 2026 eingehen. Frühzeitige Hinweise für andere Direktoren-Nominierungen oder Geschäfte müssen zwischen dem 15. Januar 2026 und dem 14. Februar 2026 vorgelegt werden. Universelle Proxy-Benachrichtigungen gemäß Regel 14a-19 müssen bis zum 16. März 2026 erfolgen.

فيايتريس إنك عدّلت وصاغت من جديد نظامها bylaws اعتباراً من 24 أكتوبر 2025، محدثة قواعد الوصول إلى التوكيل عند تغير تاريخ الاجتماع السنوي. حدّدت الشركة اجتماعها السنوي 2026 في 15 مايو 2026.

المواعيد النهائية للمساهمين: يجب تقديم مقترحات القاعدة 14a-8 قبل 24 نوفمبر 2025. يجب استلام الترشيحات للوصول إلى التوكيل (حتى الأكبر من مرشّحين اثنين أو 20% من مجلس الإدارة) بين 16 ديسمبر 2025 و15 يناير 2026. يجب تقديم إشعار مسبَق لغيرها من ترشيحات الأعضاء أو الأعمال بين 15 يناير 2026 و14 فبراير 2026. يجب تقديم إشعارات التوكيل الشامل وفق القاعدة 14a-19 قبل 16 مارس 2026.

Viatris Inc. 于2025年10月24日起修订并重新制定其公司章程生效,更新在年度股东大会日期变动时的代理访问时机规则。公司将2026年的年度股东大会定于2026年5月15日。

股东截止日期:Rule 14a-8 的提案应在 2025年11月24日之前提交。代理访问的提名(以两名提名者或董事会20%的较大者为准)应在 2025年12月16日至2026年1月15日之间收到。其他董事提名或议题的事先通知应在 2026年1月15日至2026年2月14日之间提交。Rule 14a-19 下的通用代理通知应在 2026年3月16日之前提交。


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549



FORM 8-K



CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 24, 2025



VIATRIS INC.
(Exact name of registrant as specified in its charter)



Delaware
001-39695
83-4364296
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)

1000 Mylan Boulevard, Canonsburg, Pennsylvania, 15317
(Address of Principal Executive Offices)

Registrant’s telephone number, including area code: (724) 514-1800



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))

 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
 
Trading
Symbol(s)

 
Name of each exchange
on which registered
Common Stock, par value $0.01 per share
 
VTRS
 
The NASDAQ Stock Market


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 5.03
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On October 24, 2025, the Board of Directors (the “Board”) of Viatris Inc. (“Viatris” or the “Company”) approved the Amended and Restated Bylaws of Viatris Inc. (the “Amended and Restated Bylaws”), which became effective the same date. The Amended and Restated Bylaws amended Section 2.16(b) to specify timely notice of the Notice of Proxy Access Nomination in the event the date of the annual meeting is more than 30 days before or more than 60 days after the first anniversary of the preceding year’s annual meeting. The foregoing description of the Amended and Restated Bylaws does not purport to be complete and is subject to, and qualified in its entirety by reference to, the full text of the Amended and Restated Bylaws, which are attached as Exhibit 3.1 hereto and incorporated herein by reference.


Item 5.08
Shareholder Director Nominations.

The information contained in Item 8.01 of this Current Report on Form 8-K is hereby incorporated by reference into this Item 5.08 to the extent applicable.

Item 8.01
Other Events.

After discussions with investors and in order to move to a more standard annual meeting cadence and drive further efficiency going forward, Viatris will hold its 2026 annual meeting of shareholders (the “2026 Annual Meeting”) on May 15, 2026. Further details about the 2026 Annual Meeting, including the time and location, will be set forth in the Company’s 2026 proxy statement.

The Amended and Restated Bylaws contain advance notice procedures for shareholders to make nominations of candidates for election as directors or to bring other business before the annual meeting of shareholders that is not to be included in the Company’s proxy statement. For the 2026 Annual Meeting, any shareholders notice for this purpose must be delivered to the attention of the Corporate Secretary at the principal executive offices of the Company (1000 Mylan Boulevard, Canonsburg, PA 15317) not earlier than the close of business on January 15, 2026 and not later than the close of business on February 14, 2026 and must otherwise comply with the applicable requirements in the Amended and Restated Bylaws.

Under the Company’s proxy access bylaw, as amended, if a shareholder (or a group of no more than 20 shareholders) who has owned at least 3% of the voting power of the outstanding shares of all classes of capital stock entitled to vote in the election of directors, voting together as a single class, continuously for at least three years immediately preceding the date of the notice of proxy access nomination and has otherwise complied with the requirements set forth in the Amended and Restated Bylaws wants the Company to include director nominees (up to the greater of two nominees or 20% of the Board) in the Company’s proxy statement for the 2026 Annual Meeting, the nominations must be delivered to or be mailed and received by the Secretary at the principal executive offices of the Company no earlier than December 16, 2025 and no later than January 15, 2026.

If a shareholder wishes to submit a proposal pursuant to Rule 14a-8 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), such proposal must be received by the Company at its principal executive offices to the attention of the Corporate Secretary no later than November 24, 2025 and such shareholders must otherwise comply with the requirements of Rule 14a-8 in order for the proposal to be considered for inclusion in the Company’s 2026 proxy statement and form of proxy.

In addition to satisfying the requirements under the Amended and Restated Bylaws, to comply with the universal proxy rules, shareholders who intend to solicit proxies in support of director nominees other than the Company’s nominees must also provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act no later than March 16, 2026.


Item 9.01
Financial Statements and Exhibits.

(d)
Exhibits.

Exhibit
 
No.
Description
3.1
Amended and Restated Bylaws of Viatris Inc., effective as of October 24, 2025.
104
Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


VIATRIS INC.
 
 
 
Date: October 24, 2025
By: /s/ THEODORA MISTRAS
 
 
Theodora Mistras



Viatris Inc Ord Shs

NASDAQ:VTRS

VTRS Rankings

VTRS Latest News

VTRS Latest SEC Filings

VTRS Stock Data

12.02B
1.16B
0.28%
85.61%
3.48%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
CANONSBURG